TY - JOUR
T1 - Cognitive impairment and dentate gyrus synaptic dysfunction in experimental Parkinsonism
AU - Bonito-Oliva, Alessandra
AU - Pignatelli, Marco
AU - Spigolon, Giada
AU - Yoshitake, Takashi
AU - Seiler, Stefanie
AU - Longo, Francesco
AU - Piccinin, Sonia
AU - Kehr, Jan
AU - Mercuri, Nicola B.
AU - Nisticò, Robert
AU - Fisone, Gilberto
N1 - Funding Information:
This work was supported by Swedish Research Council Grant 13482 to GF and the Italian Ministry of Education (Progetti di Rilevanza Nazionale [PRIN] 2009) to RN. Author ABO was supported by grants from the foundation Blanceflor Boncompagni-Ludovisi née Bildt, StratNeuro at Karolinska Institutet, and Åhlén-stiftelsen. We thank Mauro Federici for excellent technical support.
PY - 2014/5/1
Y1 - 2014/5/1
N2 - Background: Parkinson's disease (PD) is characterized by the progressive degeneration of the nigrostriatal dopaminergic pathway and the emergence of rigidity, tremor, and bradykinesia. Accumulating evidence indicates that PD is also accompanied by nonmotor symptoms including cognitive deficits, often manifested as impaired visuospatial memory. Methods: We studied cognitive performance and synaptic plasticity in a mouse model of PD, characterized by partial lesion of the dopaminergic and noradrenergic inputs to striatum and hippocampus. Sham- and 6-hydroxydopamine-lesioned mice were subjected to the novel object recognition test, and long-term potentiation was examined in the dentate gyrus and CA1 regions of the hippocampus. Results: Bilateral 6-hydroxydopamine lesion reduced long-term but not short-term novel object recognition and decreased long-term potentiation specifically in the dentate gyrus. These abnormalities did not depend on the loss of noradrenaline but were abolished by the antiparkinsonian drug, L-DOPA, or by SKF81297, a dopamine D1-type receptor agonist. In contrast, activation of dopamine D2-type receptors did not modify the effects produced by the lesion. Blockade of the extracellular signal-regulated kinases prevented the ability of SKF81297 to rescue novel object recognition and long-term potentiation. Conclusions: These findings show that partial dopamine depletion leads to impairment of long-term recognition memory accompanied by abnormal synaptic plasticity in the dentate gyrus. They also demonstrate that activation of dopamine D1 receptors corrects these deficits, through a mechanism that requires intact extracellular signal-regulated kinases signaling.
AB - Background: Parkinson's disease (PD) is characterized by the progressive degeneration of the nigrostriatal dopaminergic pathway and the emergence of rigidity, tremor, and bradykinesia. Accumulating evidence indicates that PD is also accompanied by nonmotor symptoms including cognitive deficits, often manifested as impaired visuospatial memory. Methods: We studied cognitive performance and synaptic plasticity in a mouse model of PD, characterized by partial lesion of the dopaminergic and noradrenergic inputs to striatum and hippocampus. Sham- and 6-hydroxydopamine-lesioned mice were subjected to the novel object recognition test, and long-term potentiation was examined in the dentate gyrus and CA1 regions of the hippocampus. Results: Bilateral 6-hydroxydopamine lesion reduced long-term but not short-term novel object recognition and decreased long-term potentiation specifically in the dentate gyrus. These abnormalities did not depend on the loss of noradrenaline but were abolished by the antiparkinsonian drug, L-DOPA, or by SKF81297, a dopamine D1-type receptor agonist. In contrast, activation of dopamine D2-type receptors did not modify the effects produced by the lesion. Blockade of the extracellular signal-regulated kinases prevented the ability of SKF81297 to rescue novel object recognition and long-term potentiation. Conclusions: These findings show that partial dopamine depletion leads to impairment of long-term recognition memory accompanied by abnormal synaptic plasticity in the dentate gyrus. They also demonstrate that activation of dopamine D1 receptors corrects these deficits, through a mechanism that requires intact extracellular signal-regulated kinases signaling.
KW - Dopamine D1 receptor
KW - Parkinson's disease
KW - extracellular signal-regulated kinases
KW - hippocampus
KW - long-term potentiation
KW - mouse
KW - novel object recognition
UR - http://www.scopus.com/inward/record.url?scp=84898919586&partnerID=8YFLogxK
U2 - 10.1016/j.biopsych.2013.02.015
DO - 10.1016/j.biopsych.2013.02.015
M3 - Article
C2 - 23541633
AN - SCOPUS:84898919586
SN - 0006-3223
VL - 75
SP - 701
EP - 710
JO - Biological Psychiatry
JF - Biological Psychiatry
IS - 9
ER -